ASP2151 Phase 1 Study - Multiple Oral Dosing Study in Healthy Non-elderly Male and Elderly Male Japanese Subjects-

Trial Profile

ASP2151 Phase 1 Study - Multiple Oral Dosing Study in Healthy Non-elderly Male and Elderly Male Japanese Subjects-

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs Amenamevir (Primary)
  • Indications Herpes simplex virus infections; Herpes zoster
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 13 Nov 2017 Results of pooled data from four phase1 trial (NCT02852876, NCT02796118, 15L-CL-001 and 15L-CL-006) assessing safety and pharmacokinetics of single and multiple doses of amenamevir, were published in the Advances in Therapy.
    • 25 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top